{
  "docId": "019de076-d751-7307-bbaf-99ca781ac1ab",
  "docSlug": "189a04348e27fe00aa9b1f85c622a168",
  "documentTitle": "Invitae | Results Presentation Deck | 31 slides",
  "authorId": "invitae",
  "authorName": "Invitae",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-02-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 19,
  "pageCount": 31,
  "prevPage": 18,
  "nextPage": 20,
  "slideType": "kpi_overview",
  "function": "analyze_data",
  "density": "dense",
  "nDataPoints": 12,
  "notes": "The slide uses a before-after framing to show growth projections for both total revenue and product mix.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-d751-7307-bbaf-99ca781ac1ab/19",
  "deckHref": "/decks/019de076-d751-7307-bbaf-99ca781ac1ab",
  "deckJsonHref": "/decks/019de076-d751-7307-bbaf-99ca781ac1ab.json",
  "deckAnchorHref": "/decks/019de076-d751-7307-bbaf-99ca781ac1ab#slide-19",
  "components": [
    {
      "bbox": {
        "h": 0.6,
        "w": 0.4,
        "x": 0.55,
        "y": 0.2
      },
      "kind": "chart",
      "text": "Product mix percentage comparison 2022 vs 2023E",
      "attrs": null,
      "subkind": "bar-stacked",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "28a8d0f2-3fe7-46b1-b508-faa1644fd7a8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.4,
        "x": 0.06,
        "y": 0.2
      },
      "kind": "chart",
      "text": "Revenue comparison 2022 vs 2023E",
      "attrs": null,
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f6ebc5b3-73da-44f6-9b5d-4f0f72184d9c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.3,
        "x": 0.65,
        "y": 0.82
      },
      "kind": "list",
      "text": "Oncology, Rare diseases / Other, Women's health, Data / Patient Network",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "68e60b90-e510-4cbf-9aa6-50c0500ed344",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.6,
        "x": 0.35,
        "y": 0.88
      },
      "kind": "source-note",
      "text": "Based on Company estimates. May not sum due to rounding. 2022 pro forma revenue represents an annualized run rate of 4Q22 revenue that excludes all exited revenue due to realignment. *Drawings not to scale",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "334babf2-fa94-4f25-b9e9-6c580dd13e71",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.35,
        "x": 0.04,
        "y": 0.06
      },
      "kind": "title",
      "text": "2023 financial guidance",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0860d50b-7b5a-45fd-b947-cb235b474ada",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "before-after-framing",
      "slug": null,
      "matchId": "4d4e37ab-a652-4b9e-bb43-2c58e6e37020",
      "evidence": "The slide compares 2022 actuals/pro-forma against 2023 estimates to show growth.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 20,
      "from": 19,
      "beatId": "275d8b00-0176-403f-988d-f5111edcbf5f",
      "arcName": "Rags to Riches",
      "arcSlug": "rags-to-riches",
      "beatName": "The Breakthrough",
      "beatSlug": "rags-to-riches-the-breakthrough",
      "evidence": "The 2023 financial guidance slides highlight Invitae's new path forward and growth prospects.",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}